A.J.M. Loonen

3.6k citations

161 papers · 2.4k indexed · h-index 26

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment

Papers in

Biological Psychiatry 16
- Tryptophan and brain disorders 16
Psychiatry and Mental health 70
- Schizophrenia research and treatment 49
- Bipolar Disorder and Treatment 20
- Epilepsy research and treatment 11

Co-authors: Svetlana А. Ivanova Н. А. Бохан A. Semke Olga Fedorenko Anastasiia S. Boiko Bob Wilffert Elena G. Kornetova Jim van Os
Journals: European Neuropsychopharmacology (10 papers)Human Psychopharmacology Clinical and Experimental (5 papers)Pharmacopsychiatry (5 papers)Frontiers in Psychiatry (4 papers)The World Journal of Biological Psychiatry (4 papers)
Partner nations: Netherlands Russia New Zealand

In The Last Decade

A.J.M. Loonen

155 papers receiving 2.3k citations

Peers

Countries citing papers authored by A.J.M. Loonen

Since Specialization

Citations

This map shows the geographic impact of A.J.M. Loonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J.M. Loonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J.M. Loonen more than expected).

Fields of papers citing papers by A.J.M. Loonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.J.M. Loonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J.M. Loonen. The network helps show where A.J.M. Loonen may publish in the future.

Co-authors

The 25 scholars most cited alongside A.J.M. Loonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.J.M. Loonen Line = papers co-authored together A.J.M. Loonen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome Genes ·Anastasiia S. Boiko, Ivan V. Pozhidaev, Diana Z. Paderina, Irina A. Mednova, A. A. Goncharova, Olga Fedorenko, Elena G. Kornetova, A. Semke, Н. А. Бохан, A.J.M. Loonen, Svetlana А. Ivanova	2022	5
2	Circuits regulating pleasure and happiness – focus on potential biomarkers for circuitry including the habenuloid complex Acta Neuropsychiatrica ·A.J.M. Loonen, Svetlana А. Ivanova	2022	13
3	Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms Life ·E. G. Poltavskaya, Olga Fedorenko, Elena G. Kornetova, A.J.M. Loonen, А. Н. Корнетов, Н. А. Бохан, Svetlana А. Ivanova	2021	20
4	Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression Journal of Clinical Medicine ·Olga V. Roschina, Л. А. Левчук, Anastasiia S. Boiko, Ekaterina V. Mikhalitskaya, Elena V. Epimakhova, Innokentiy S. Losenkov, Г. Г. Симуткин, A.J.M. Loonen, Н. А. Бохан, Svetlana А. Ivanova	2021	8
5	Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients Pharmacogenomics and Personalized Medicine ·Anastasiia S. Boiko, Ivan V. Pozhidaev, Diana Z. Paderina, А. В. Бочарова, Irina A. Mednova, Olga Fedorenko, Elena G. Kornetova, A.J.M. Loonen, A. Semke, Н. А. Бохан, Svetlana А. Ivanova	2021	11
6	Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia Journal of Personalized Medicine ·Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev, А. В. Бочарова, Irina A. Mednova, Olga Fedorenko, Elena G. Kornetova, A.J.M. Loonen, A. Semke, Н. А. Бохан, Svetlana А. Ivanova	2021	12
7	Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design Human Psychopharmacology Clinical and Experimental ·Lisanne M. Geers, Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Г. Г. Симуткин, Н. А. Бохан, Bob Wilffert, Daan J. Touw, A.J.M. Loonen, Svetlana А. Ivanova	2021	7
8	Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics Pharmaceuticals ·Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, V. I. Gerasimova, А. Н. Корнетов, A.J.M. Loonen, Н. А. Бохан, Svetlana А. Ivanova	2021	15
9	Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action Journal of Personalized Medicine ·Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, A.J.M. Loonen, Г. Г. Симуткин, Н. А. Бохан, Bob Wilffert, Svetlana А. Ivanova	2021	4
10	<p>Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia</p> Neuropsychiatric Disease and Treatment ·Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, Н. А. Бохан, A. Semke, A.J.M. Loonen, Svetlana А. Ivanova	2020	14
11	Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia Human Psychopharmacology Clinical and Experimental ·Olga Fedorenko, Diana Z. Paderina, A.J.M. Loonen, Ivan V. Pozhidaev, Anastasiia S. Boiko, Elena G. Kornetova, Н. А. Бохан, Bob Wilffert, Svetlana А. Ivanova	2020	3
12	Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke Brain Sciences ·Е. С. Королева, И. В. Толмачев, В. М. Алифирова, Anastasiia S. Boiko, Л. А. Левчук, A.J.M. Loonen, Svetlana А. Ivanova	2020	23
13	Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome Diagnostics ·Elena G. Kornetova, А. Н. Корнетов, Irina A. Mednova, О. А. Лобачева, V. I. Gerasimova, V. Dubrovskaya, И. В. Толмачев, A. Semke, A.J.M. Loonen, Н. А. Бохан, Svetlana А. Ivanova	2020	14
14	Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients Journal of Affective Disorders ·Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Л. А. Левчук, Diana Z. Osmanova, Ekaterina V. Mikhalitskaya, A.J.M. Loonen, Fokko J. Bosker, Г. Г. Симуткин, Н. А. Бохан, Bob Wilffert, Svetlana А. Ivanova	2019	11
15	The functional variant rs334558 of <em>GSK3B</em> is associated with remission in patients with depressive disorders Pharmacogenomics and Personalized Medicine ·Аnastasia Levchenko, Innokentiy S. Losenkov, Natalya M. Vyalova, Г. Г. Симуткин, Н. А. Бохан, Bob Wilffert, A.J.M. Loonen, Svetlana А. Ivanova	2018	11
16	Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia Journal of Pharmacy & Pharmaceutical Sciences ·Svetlana А. Ivanova, В. М. Алифирова, Ivan V. Pozhidaev, Maxim B. Freidin, Irina Zhukova, Diana Z. Osmanova, Н. Г. Жукова, Yulia A. Mironova, V. V. Tiguntsev, Olga Fedorenko, Н. А. Бохан, Bob Wilffert, A.J.M. Loonen	2018	10
17	ROLE OF 5-HT2C RECEPTORS IN DYSKINESIA International Journal of Pharmacy and Pharmaceutical Sciences ·A.J.M. Loonen, Svetlana А. Ivanova	2015	7
18	Individually-tailored intervention promotes treatment adherence in psychotic patients: A randomized controlled trial (RCT) Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Anton B. P. Staring, Mark van der Gaag, Gerrit T. Koopmans, Jean‐Paul Selten, Nico van Beveren, A.J.M. Loonen, Niels L. Mulder	2011	1
19	Visualizing Pharmacological Activities of Antidepressants: A Novel Approach Data Archiving and Networked Services (DANS) ·Hieronymus J. Derijks, Eibert R. Heerdink, R. Janknegt, Fred H.P. De Koning, Berend Olivier, A.J.M. Loonen, Toine C. G. Egberts	2008	24
20	Effects of halopemide, a new psychotropic agent, on the uptake of serotonin by blood platelets. University of Groningen research database (University of Groningen / Centre for Information Technology) ·A.J.M. Loonen, W. Soudijn	1979	5

About A.J.M. Loonen

A.J.M. Loonen is a scholar working on Biological Psychiatry, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Behavioral Neuroscience and Toxicology, having authored 161 papers that have together received 2.4k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (49 papers), Neuroscience and Neuropharmacology Research (25 papers), Bipolar Disorder and Treatment (20 papers), Neurotransmitter Receptor Influence on Behavior (17 papers), Tryptophan and brain disorders (16 papers), Neurological disorders and treatments (16 papers), Treatment of Major Depression (14 papers) and Epilepsy research and treatment (11 papers). The work is most often cited by research in Biological Psychiatry (286 citations), Psychiatry and Mental health (916 citations), Behavioral Neuroscience (116 citations), Cellular and Molecular Neuroscience (581 citations) and Neurology (343 citations). A.J.M. Loonen has collaborated with scholars based in Netherlands, Russia and New Zealand. Frequent co-authors include Svetlana А. Ivanova, Н. А. Бохан, A. Semke, Olga Fedorenko, Anastasiia S. Boiko, Bob Wilffert, Elena G. Kornetova, Jim van Os, Nil Kaymaz and W. Soudijn. Their work appears in journals such as European Neuropsychopharmacology, Human Psychopharmacology Clinical and Experimental, Pharmacopsychiatry, Frontiers in Psychiatry and The World Journal of Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact